Savara Inc Stock Investor Sentiment

SVRA Stock  USD 3.36  0.11  3.17%   
About 62% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
  

Savara Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Savara can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at businesswire.com         
Savara Announces Pricing of 100.0 Million Underwritten Offering of Common Stock
businesswire News
over three months ago at finance.yahoo.com         
Savara Announces Molgramostim Nebulizer Solution Achieved Statistical Significance for Primary Endpo...
Yahoo News
over three months ago at benzinga.com         
Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday?
benzinga news
over three months ago at seekingalpha.com         
Savara stock surges on trial win for lead asset
seekingalpha News
over three months ago at businesswire.com         
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molg...
businesswire News
over three months ago at businesswire.com         
Savara Announces Molgramostim Nebulizer Solution Achieved Statistical Significance for Primary Endpo...
businesswire News
over three months ago at businesswire.com         
Savara Announces Molgramostim Nebulizer Solution Achieved Statistical Significance for Primary Endpo...
businesswire News
over three months ago at businesswire.com         
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molg...
businesswire News
over three months ago at businesswire.com         
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molg...
businesswire News
over three months ago at businesswire.com         
Savara Announces Molgramostim Nebulizer Solution Achieved Statistical Significance for Primary Endpo...
businesswire News
over three months ago at businesswire.com         
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molg...
businesswire News
over three months ago at finance.yahoo.com         
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molg...
Yahoo News
over three months ago at businesswire.com         
Savara Announces Molgramostim Nebulizer Solution Achieved Statistical Significance for Primary Endpo...
businesswire News
over three months ago at news.google.com         
3 Penny Stocks Poised for Major Upside Over the Next 5 Years - InvestorPlace
Google News at Macroaxis
over three months ago at news.google.com         
Savara Inc Receives Average Recommendation of Buy from Brokerages - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Savara that are available to investors today. That information is available publicly through Savara media outlets and privately through word of mouth or via Savara internal channels. However, regardless of the origin, that massive amount of Savara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Savara news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Savara relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Savara's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Savara alpha.

Savara Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Mathers Edward T of 333333 shares of Savara at 3.0 subject to Rule 16b-3
09/13/2024
2
Acquisition by Pratt Raymond Dennis of 3500 shares of Savara at 1.5434 subject to Rule 16b-3
09/20/2024
3
Savara Announces Expanded Access Program for Molgramostim Inhalation Solution for Patients with Autoimmune Pulmonary Alveolar Proteinosis
09/27/2024
4
Acquisition by Elam Nevan C of 1758 shares of Savara at 0.82 subject to Rule 16b-3
10/17/2024
5
Disposition of 381 shares by Anne Erickson of Savara at 3.57 subject to Rule 16b-3
10/21/2024
6
Savara Announces the Rare Lung Disease, Autoimmune Pulmonary Alveolar Proteinosis , is Highlighted on a New Episode of The Balancing Act Airing on Lifetime TV
10/22/2024
7
Disposition of 49950 shares by Pratt Raymond Dennis of Savara at 3.97 subject to Rule 16b-3
11/08/2024
8
Jennison Associates LLCs Strategic Acquisition of Savara Inc Shares
11/13/2024
9
Acquisition by Ramsay David A of 100000 shares of Savara at 2.876 subject to Rule 16b-3
11/18/2024
10
Director David Ramsay Acquires 100,000 Shares of Savara Inc
11/19/2024
11
Independent Director of Savara Picks Up 4.5 percent More Stock
11/21/2024
12
Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution in Patients with Autoimmune Pulmonary Alveol...
11/22/2024
13
Estimating The Fair Value Of Savara Inc.
11/25/2024
14
Vestal Point Capital LP Raises Holdings in Savara Inc
11/29/2024

Complementary Tools for Savara Stock analysis

When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.